Healthcare & Pharma

The RNA therapeutics market was valued at US$5,876.7 million in 2021 and is projected to grow at a CAGR of 18.68% during the forecast period 2022-2032.

The antisense oligonucleotide therapeutics market was valued at US$17.46 billion in 2021 and is projected to grow at a CAGR of 13.71% during the forecast period 2022-2032.

The viral vectors and plasmid DNA manufacturing market was valued at US$482.3 million in 2021 and is projected to grow at a CAGR of 18.09% during the forecast period 2022-2032.

The OTC drugs & dietary supplements market was valued at US$211.75 billion in 2021 and is projected to grow at a CAGR of 7.90% during the forecast period 2022-2032.

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

The Global Clinical Trial Supply & Logistics market was valued at US$20.0 billion in 2021 and is projected to grow at a CAGR of 8.06% during the forecast period 2022-2032.

Ophthalmic drugs market was valued at US$29.07 billion in 2022 and is projected to grow at a CAGR of 6.39% during the forecast period 2023-2033.

The global molecular diagnostics market was valued at US$23,498.2 million in 2022 and is projected to grow at a CAGR of 7.28% during the forecast period 2022-2032.

The Global Anti-Infective Vaccines Market was valued at US$53,03 billion in 2021 and is projected to grow at a CAGR of 12.51% during the forecast period 2022-2032.

The global mRNA Vaccines & Therapeutics market was valued at US$58,452.6 million in 2021 and is projected to change at a CAGR of -7.89% during the forecast period 2022-2032.

The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at a CAGR of 9.95% during the forecast period 2022-2032.

The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.

The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR of 25.52% during the forecast period 2022-2032.

The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a CAGR of 23.5% during the forecast period 2022-2032.

The global drug discovery services market is anticipated to be valued at US$14.17 billion in 2022 and is projected to grow at a CAGR of 15.17% during the forecast period 2022-2032.

The global biobanking market was valued at US$56,955 million in 2021 and is projected to grow at a CAGR of 4.67% during the forecast period 2022-2032.